SNARE介膜融合の局所的界面活性剤モデル
Josep Rizo1,2,3, Madhurima Chattopadhyay1,2,3, Aleksandra Wosztyl1,2,3
1Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Journal of cell science
|January 22, 2026
まとめ
可溶性N-エチルマレイミド感受性因子タンパク質受容体(SNARE)は、剛直な棒ではなく界面活性剤として作用する可能性がある。このメカニズムは、生物学的膜融合に不可欠な膜内部混合をSNAREがどのように触媒するかを説明する。
科学分野:
- 分子生物学
- 生物物理学
- 細胞生物学
背景:
- 従来のモデルでは、膜の反発が融合の主な障壁であると提案されている。
- 可溶性N-エチルマレイミド感受性因子タンパク質受容体(SNARE)は、剛直ならせん構造を形成することによって反発を克服すると考えられている。
研究 の 目的:
- 膜融合の代替モデルを示唆する分子動力学シミュレーションのレビュー。
- SNAREが疎水性膜混合を促進する界面活性剤として作用するという仮説を提唱する。
主な方法:
- 最近の分子動力学シミュレーションのレビュー。
- 細胞間およびウイルス細胞融合タンパク質の構造特性の分析。
主要な成果:
- 膜内部の混合は、反発ではなく、融合の主な障害である。
- SNAREは、疎水性混合を触媒する局所的な界面活性剤として機能する可能性が高い。
- SNAREは、ストーク様構造と融合孔の形成を促進する。
結論:
- SNAREが界面活性剤として作用し、膜融合を触媒するという新しいモデル。
- SNAREのこの界面活性剤様機能は、様々な生物学的膜融合にわたる普遍的なメカニズムである可能性がある。
さらに関連する動画
関連する概念動画
SNAREs and Membrane Fusion
12.5K
Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
12.5K
Detergent Purification of Membrane Proteins
6.3K
Detergents are used to purify the integral proteins of the membrane. The hydrophobic portion of the detergent can replace membrane phospholipids while solubilizing the membrane proteins. When detergent monomers reach a specific concentration in a solution called critical micelle concentration (CMC), they form micelles. Above CMC, the concentration of the detergent monomers remains in equilibrium with the micelle. The number of detergent monomers present in the CMC varies for each detergent, and...
6.3K
Fusion of Secretory Vesicles with the Plasma Membrane
16.6K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
16.6K
Nuclear Fusion
33.7K
The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
33.7K
Receptor-mediated Endocytosis
110.6K
Overview
110.6K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
5.9K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
5.9K


